{"pub": "washingtontimes", "url": "https://washingtontimes.com/news/2019/oct/18/european-medicines-agency-recommends-licensing-ebo", "downloaded_at": "2019-10-18 11:49:15.262912+00:00", "title": "European Medicines Agency recommends licensing Ebola vaccine", "language": "en", "text": "LONDON (AP) - The European Medicines Agency has recommended that the world\u2019s first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa.\n\nThe agency on Friday described licensing the vaccine as \u201can important step toward relieving the burden of this deadly disease.\u201d The Ebola vaccine was originally developed in Canada and is now marketed by Merck as Ervebo. More than 270,000 people in Africa have received it as officials try to stop Congo\u2019s ongoing outbreak.\n\nA second vaccine made by Johnson & Johnson, which is not yet licensed, will soon be used in parts of Congo where Ebola is not actively spreading.\n\nAlso Friday, the World Health Organization is convening a meeting to consider whether the epidemic in Congo should still be designated a global emergency.\n\nSign up for Daily Newsletters Manage Newsletters\n\nCopyright \u00a9 2019 The Washington Times, LLC.", "description": "The European Medicines Agency has recommended that the world's first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa.", "authors": ["The Washington Times Http"], "top_image": "", "published_at": "2019-10-18"}